Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura

Clinical trial NCT01713855 · COMPLETED

Trial details

NCT number: NCT01713855
Sponsor: Neufeld, Ellis J, MD, PhD
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura Immune Thrombocytopenic Purpura

Start date: 2004-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.